Lifemd Inc Stock Today

LFMD Stock  USD 5.94  0.28  4.95%   

Performance

Insignificant

 
Weak
 
Strong

Odds Of Distress

Very High

 
High
 
Low
LifeMD is trading at 5.94 as of the 16th of March 2025, a 4.95 percent increase since the beginning of the trading day. The stock's lowest day price was 5.44. LifeMD has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 16th of December 2024 and ending today, the 16th of March 2025. Click here to learn more.
Business Domain
Health Care Equipment & Services
IPO Date
2nd of January 2001
Category
Healthcare
Classification
Health Care
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, mens sexual health, dermatology, and others in the United States. LifeMD, Inc. The company has 44.58 M outstanding shares of which 5.11 M shares are now shorted by private and institutional investors with about 4.85 trading days to cover. More on LifeMD Inc

Moving against LifeMD Stock

  0.44DXR DaxorPairCorr

LifeMD Stock Highlights

ESG Sustainability
Environmental
Governance
Social
Business ConcentrationHealth Care Equipment & Supplies, Health Care Equipment & Services, Health Care, Nasdaq Benchmark Consumer, NASDAQ Composite, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Pharmaceutical Retailers, Healthcare (View all Sectors)
Average Analyst Recommendation
Debt Levels
LifeMD can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand LifeMD's financial leverage. It provides some insight into what part of LifeMD's total assets is financed by creditors.
Liquidity
LifeMD Inc currently holds 15.22 T in liabilities with Debt to Equity (D/E) ratio of 0.46, which is about average as compared to similar companies. LifeMD Inc has a current ratio of 0.51, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about LifeMD's use of debt, we should always consider it together with its cash and equity.

Change In Cash

2.75 Million
LifeMD Inc (LFMD) is traded on NASDAQ Exchange in USA. It is located in 236 Fifth Avenue, New York, NY, United States, 10001 and employs 304 people. LifeMD is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 264.83 M. LifeMD Inc conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 44.58 M outstanding shares of which 5.11 M shares are now shorted by private and institutional investors with about 4.85 trading days to cover. LifeMD Inc currently holds about 5.84 M in cash with 17.51 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.19.
Check LifeMD Probability Of Bankruptcy
Ownership Allocation
LifeMD Inc maintains a total of 44.58 Million outstanding shares. 30% of LifeMD outstanding shares are owned by institutional investors. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check LifeMD Ownership Details

LifeMD Stock Institutional Holders

InstituionRecorded OnShares
Uniplan Investment Counsel, Inc.2024-12-31
385.3 K
Marshall Wace Asset Management Ltd2024-12-31
371.5 K
Qube Research & Technologies2024-12-31
324.5 K
Northern Trust Corp2024-12-31
324 K
Bridgeway Capital Management, Llc
269.2 K
Aqr Capital Management Llc2024-12-31
263.9 K
Ubs Group Ag2024-12-31
244.9 K
Quinn Opportunity Partners Llc2024-12-31
234.2 K
Bank Of New York Mellon Corp2024-12-31
210.3 K
Blackrock Inc2024-12-31
2.5 M
Vanguard Group Inc2024-12-31
1.8 M
View LifeMD Diagnostics

LifeMD Historical Income Statement

At present, LifeMD's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Selling General Administrative is expected to grow to about 76.3 M, whereas EBIT is forecasted to decline to (17 M). View More Fundamentals

LifeMD Stock Against Markets

LifeMD Corporate Management

When determining whether LifeMD Inc is a strong investment it is important to analyze LifeMD's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact LifeMD's future performance. For an informed investment choice regarding LifeMD Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LifeMD Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LifeMD. If investors know LifeMD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about LifeMD listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.53)
Revenue Per Share
5.157
Quarterly Revenue Growth
0.432
Return On Assets
(0.15)
Return On Equity
(24.63)
The market value of LifeMD Inc is measured differently than its book value, which is the value of LifeMD that is recorded on the company's balance sheet. Investors also form their own opinion of LifeMD's value that differs from its market value or its book value, called intrinsic value, which is LifeMD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because LifeMD's market value can be influenced by many factors that don't directly affect LifeMD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between LifeMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if LifeMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LifeMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.